These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37354045)

  • 21. Efficacy of Zinc Supplement in Minimal hepatic Encephalopathy: A prospective, Randomized Controlled Study (Zinc-MHE Trial).
    Janyajirawong R; Vilaichone RK; Sethasine S
    Asian Pac J Cancer Prev; 2021 Sep; 22(9):2879-2887. PubMed ID: 34582657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and Treatment of Low-Grade Hepatic Encephalopathy.
    Direkze S; Jalan R
    Dig Dis; 2015; 33(4):562-9. PubMed ID: 26159274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent.
    Gupta D; Ingle M; Shah K; Phadke A; Sawant P
    J Dig Dis; 2015 Jul; 16(7):400-7. PubMed ID: 25858627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study.
    Gairing SJ; Mangini C; Zarantonello L; Gioia S; Nielsen EJ; Danneberg S; Gabriel M; Ehrenbauer AF; Bloom PP; Ripoll C; Sultanik P; Galle PR; Labenz J; Thabut D; Zipprich A; Lok AS; Weissenborn K; Marquardt JU; Lauridsen MM; Nardelli S; Montagnese S; Labenz C
    Am J Gastroenterol; 2023 Dec; 118(12):2191-2200. PubMed ID: 36940426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
    Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal Hepatic Encephalopathy in Patients with Alcohol Related and Non-alcoholic Steatohepatitis Related Cirrhosis by Psychometric Hepatic Cephalopathy Score and Critical Flicker Frequency.
    Jagtap N; Bhakhar P; Miftahussurur M; S YH; Shrimal P; Sharma M; Gupta R; Rao PN; Reddy DN
    Acta Med Indones; 2021 Jan; 53(1):24-30. PubMed ID: 33818404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients.
    Labenz C; Baron JS; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
    Aliment Pharmacol Ther; 2018 Aug; 48(3):313-321. PubMed ID: 29863286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Montoliu C; Cauli O; Urios A; ElMlili N; Serra MA; Giner-Duran R; González-Lopez O; Del Olmo JA; Wassel A; Rodrigo JM; Felipo V
    Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy.
    Moratalla A; Ampuero J; Bellot P; Gallego-Durán R; Zapater P; Roger M; Figueruela B; Martínez-Moreno B; González-Navajas JM; Such J; Romero-Gómez M; Francés R
    Liver Int; 2017 Feb; 37(2):212-223. PubMed ID: 27388776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients.
    Giménez-Garzó C; Garcés JJ; Urios A; Mangas-Losada A; García-García R; González-López O; Giner-Durán R; Escudero-García D; Serra MA; Soria E; Felipo V; Montoliu C
    PLoS One; 2017; 12(2):e0171211. PubMed ID: 28146589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy.
    Felipo V; Urios A; Valero P; Sánchez M; Serra MA; Pareja I; Rodríguez F; Gimenez-Garzó C; Sanmartín J; Montoliu C
    Liver Int; 2013 Nov; 33(10):1478-89. PubMed ID: 23714168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EncephalApp Stroop App predicts poor sleep quality in patients with minimal hepatic encephalopathy due to hepatitis B-induced liver cirrhosis.
    Luo M; Yu XB; Hu SJ; Bai FH
    Saudi J Gastroenterol; 2020; 26(3):120-128. PubMed ID: 32270775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY IN ROMANIAN CIRRHOTIC PATIENTS--PARTIAL RESULTS.
    Badea MA; Prelipcean CC; Mihai C; Popa I; Drug VL
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):368-73. PubMed ID: 26204638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normalisation of the psychometric encephalopathy score within the Cameroonian population.
    Pessidjo Djomatcho L; Kowo MP; Ndam AN; Njonnou SRS; Kenfack GU; Andoulo FA; Bagnaka SFE; Bekolo WT; Malongue A; Babagna ID; Sida MB; Luma H; Njoya O
    BMC Gastroenterol; 2021 Jul; 21(1):287. PubMed ID: 34247589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits.
    Urios A; Mangas-Losada A; Gimenez-Garzó C; González-López O; Giner-Durán R; Serra MA; Noe E; Felipo V; Montoliu C
    Liver Int; 2017 Jul; 37(7):1013-1022. PubMed ID: 27988985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
    Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal naming test for the assessment of minimal hepatic encephalopathy in Asian cirrhotic populations.
    Qu Y; Li T; Lin C; Liu F; Wu S; Wang L; Ye Q
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101729. PubMed ID: 34091081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.